BioSyntagma Overview

  • Founded
  • 2015

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $735K

  • Investors
  • 3

BioSyntagma General Information


Operator of a precision medicine company intended to develop a microfluidic platform. The company's services include developing a microfluidic platform which allows researchers to identify single cells of interest in Formalin Fixed Paraffin Embedded (FFPE) or fresh frozen tissue, ablate the cell and transfer its contents to a downstream collection device, enabling healthcare givers to achieve a complete and informed understanding of the patient's cancer and match them with relevant therapies and recommended course of actions that prevent acquired drug resistance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Decision/Risk Analysis
Primary Office
  • 1475 North Scottsdale Road
  • Suite 200
  • Scottsdale, AZ 85257
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioSyntagma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Jan-2018 $735K Completed Startup
3. Accelerator/Incubator 20-Sep-2017 Completed Startup
2. Grant 01-Jan-2017 $214K Completed Startup
1. Grant 17-Mar-2016 $30K Completed Startup
To view BioSyntagma’s complete valuation and funding history, request access »

BioSyntagma Executive Team (3)

Name Title Board Seat Contact Info
David Richardson Founding Member & Chief Executive Officer
Dmitry Derkach MD Chief Scientific Officer
Colleen Ziegler Co-Founder & Research Technician
To view BioSyntagma’s complete executive team members history, request access »

BioSyntagma Board Members (1)

Name Representing Role Since
Steve Pemberton BioSyntagma Board Member 000 0000
To view BioSyntagma’s complete board members history, request access »

BioSyntagma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Center for Entrepreneurial Innovation Accelerator/Incubator 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
Flinn Foundation Accelerator/Incubator 000 0000 000000 0
To view BioSyntagma’s complete investors history, request access »